<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Outset Medical Inc — News on 6ix</title>
<link>https://6ix.com/company/outset-medical-inc</link>
<description>Latest news and press releases for Outset Medical Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 27 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/outset-medical-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835a66f78dffbe2df10b852.webp</url>
<title>Outset Medical Inc</title>
<link>https://6ix.com/company/outset-medical-inc</link>
</image>
<item>
<title>Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-to-report-first-quarter-2026-financial-results-on-thursday-may-7-2026</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-to-report-first-quarter-2026-financial-results-on-thursday-may-7-2026</guid>
<pubDate>Mon, 27 Apr 2026 20:05:00 GMT</pubDate>
<description>SAN JOSE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced that it will release financial results for the first quarter 2026 after the close of trading on Thursday, May 7, 2026. On the same day, at 1:30 p.m. Pacific time (4:30 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and R</description>
</item>
<item>
<title>Osisko Metals Announces Significant Increase in Mineral Resources at Gaspé Copper</title>
<link>https://6ix.com/company/outset-medical-inc/news/osisko-metals-announces-significant-increase-in-mineral-resources-at-gaspe-copper-1</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/osisko-metals-announces-significant-increase-in-mineral-resources-at-gaspe-copper-1</guid>
<pubDate>Tue, 14 Apr 2026 10:00:00 GMT</pubDate>
<description>Base Case Outlines M&I Resources of 1.83 Billion tonnes at 0.27% Cu and Inferred Resources of 0.24 Billion tonnes at 0.41% Cu 2026 Drill Program to Commence at Month End to Further Infill and Expand Resource DPEX Drill Program to Commence in May MONTREAL, April 14, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “Company” or “Osisko Metals”) (TSX: OM; OTCQX: OMZNF) is pleased to announce an updated Mineral Resource Estimate (“MRE”) for the Gaspé Copper Project, located in Eastern Quebec</description>
</item>
<item>
<title>Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-reports-inducement-grant-under-nasdaq-listing-rule-5635c4</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-reports-inducement-grant-under-nasdaq-listing-rule-5635c4</guid>
<pubDate>Wed, 08 Apr 2026 04:00:00 GMT</pubDate>
<description>SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology</description>
</item>
<item>
<title>Outset Medical Names Derick Elliott as Executive Vice President of Commercial</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-names-derick-elliott-as-executive-vice-president-of-commercial</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-names-derick-elliott-as-executive-vice-president-of-commercial</guid>
<pubDate>Mon, 06 Apr 2026 04:00:00 GMT</pubDate>
<description>SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology</description>
</item>
<item>
<title>Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-reports-fourth-quarter-210200925</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-reports-fourth-quarter-210200925</guid>
<pubDate>Wed, 11 Feb 2026 21:02:00 GMT</pubDate>
<description>SAN JOSE, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter, Year-End and Recent Highlights Net revenue totaled $28.9 million in the fourth quarter, bringing revenue in 2025 to $119.5 million, a 5% increase over $113.7 million in 202</description>
</item>
<item>
<title>Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned</title>
<link>https://6ix.com/company/outset-medical-inc/news/next-generation-tablo-hemodialysis-system-140000306</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/next-generation-tablo-hemodialysis-system-140000306</guid>
<pubDate>Tue, 27 Jan 2026 14:00:00 GMT</pubDate>
<description>Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standardsSAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) of its next-generation Tablo platform, designed to deliver enterprise-level security, reliability and</description>
</item>
<item>
<title>Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-report-fourth-quarter-210500134</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-report-fourth-quarter-210500134</guid>
<pubDate>Mon, 26 Jan 2026 21:05:00 GMT</pubDate>
<description>SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full-year 2025 after the close of trading on Wednesday, February 11, 2026. On the same day, at 1:30 p.m. Pacific time (4:30 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Renee</description>
</item>
<item>
<title>Outset Medical Reports Unaudited Fourth Quarter and 2025 Results</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-reports-unaudited-fourth-133000923</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-reports-unaudited-fourth-133000923</guid>
<pubDate>Mon, 12 Jan 2026 13:30:00 GMT</pubDate>
<description>Appoints Medical Technology Veteran Karen N. Prange to Board of DirectorsSAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2025, and named Karen N. Prange to its board of directors. Unaudited Fourth Quarter and 2025 Results Revenue in the fourth quarter totaled</description>
</item>
<item>
<title>Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-present-44th-annual-210500192</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-present-44th-annual-210500192</guid>
<pubDate>Mon, 05 Jan 2026 21:05:00 GMT</pubDate>
<description>SAN JOSE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Chair & CEO Leslie Trigg will present at the 44th annual J.P. Morgan Healthcare conference on Wednesday, January 14, 2026, at 4:30 p.m. Pacific time. A live and archived webcast of the presentation will be available on the “Investors” section of the Outset websit</description>
</item>
<item>
<title>Outset Medical Reports Third-Quarter Results</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-reports-third-quarter-210500846</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-reports-third-quarter-210500846</guid>
<pubDate>Mon, 10 Nov 2025 21:05:00 GMT</pubDate>
<description>SAN JOSE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the third quarter ended September 30, 2025 and revised its 2025 revenue guidance. Third Quarter and Recent Highlights Net revenue of $29.4 million grew 3% from the prior year period, driven by an 8% increase in Tablo console revenue.Recurring revenue consist</description>
</item>
<item>
<title>New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical’s Tablo® Hemodialysis System</title>
<link>https://6ix.com/company/outset-medical-inc/news/research-demonstrates-advantages-insourced-dialysis-210500070</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/research-demonstrates-advantages-insourced-dialysis-210500070</guid>
<pubDate>Wed, 05 Nov 2025 21:05:00 GMT</pubDate>
<description>Data from over 1 Million Tablo Treatments Among the Findings Presented at the American Society of Nephrology’s Kidney Week 2025SAN JOSE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced new research findings from over 1 million Tablo hemodialysis treatments across approximately 750 facilities, and 5-year results from the inso</description>
</item>
<item>
<title>Outset Medical to Present at the 2025 Stifel Healthcare Conference</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-present-2025-stifel-140000172</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-present-2025-stifel-140000172</guid>
<pubDate>Wed, 05 Nov 2025 14:00:00 GMT</pubDate>
<description>SAN JOSE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 2025 Stifel Healthcare conference on Wednesday, November 12, 2025, at 10:40 a.m. Eastern time. A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://</description>
</item>
<item>
<title>Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-report-third-quarter-200500428</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-report-third-quarter-200500428</guid>
<pubDate>Mon, 27 Oct 2025 20:05:00 GMT</pubDate>
<description>SAN JOSE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter 2025 after the close of trading on Monday, November 10, 2025. On the same day, at 1:30 p.m. Pacific time (4:30 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Renee Gaeta, Chief Fina</description>
</item>
<item>
<title>Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis</title>
<link>https://6ix.com/company/outset-medical-inc/news/northwest-kidney-centers-outset-medical-130000462</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/northwest-kidney-centers-outset-medical-130000462</guid>
<pubDate>Wed, 03 Sep 2025 13:00:00 GMT</pubDate>
<description>Collaboration to provide patients and caregivers access to innovative home dialysis with the Tablo® Hemodialysis SystemSAN JOSE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Northwest Kidney Centers, the first organization to establish a home hemodialysis program, today announced a collaboration with Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company transforming the dialysis experience across the continuum of care. Through the collaboration, Northwest Kidney Centers will a</description>
</item>
<item>
<title>Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-present-23rd-annual-200500106</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-present-23rd-annual-200500106</guid>
<pubDate>Wed, 20 Aug 2025 20:05:00 GMT</pubDate>
<description>SAN JOSE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the 23rd annual Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 10, 2025, at 7 a.m. Eastern time. A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at http</description>
</item>
<item>
<title>Outset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and Utilization</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-second-quarter-results-200200401</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-second-quarter-results-200200401</guid>
<pubDate>Wed, 06 Aug 2025 20:02:00 GMT</pubDate>
<description>Company raises 2025 revenue guidance to a range of $122 million to $126 millionSAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the second quarter ended June 30, 2025. Second Quarter and Recent Highlights Net revenue of $31.4 million grew 15% from the prior-year period, driven by a 25% increase in Tablo co</description>
</item>
<item>
<title>Outset Medical Names First Chief Nursing Officer</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-names-first-chief-130100107</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-names-first-chief-130100107</guid>
<pubDate>Wed, 30 Jul 2025 13:01:00 GMT</pubDate>
<description>Accomplished nursing executive to lead Outset’s clinical education and support programs for the dialysis nursing communitySAN JOSE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced Brittni McGill has been named to the newly created role of Chief Nursing Officer where she will apply her extensive nurse executive leadership exp</description>
</item>
<item>
<title>Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-to-report-second-quarter-2025-financial-results-on-wednesday-august-6-2025</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-to-report-second-quarter-2025-financial-results-on-wednesday-august-6-2025</guid>
<pubDate>Wed, 16 Jul 2025 04:00:00 GMT</pubDate>
<description>SAN JOSE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind</description>
</item>
<item>
<title>iRhythm Technologies Announces Board Member Retirements and New Director Appointments</title>
<link>https://6ix.com/company/outset-medical-inc/news/irhythm-technologies-announces-board-member-retirements-and-new-director-appointments-2</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/irhythm-technologies-announces-board-member-retirements-and-new-director-appointments-2</guid>
<pubDate>Mon, 07 Jul 2025 12:30:00 GMT</pubDate>
<description>SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the retirement of two long-serving board members, Mark Rubash and Ralph Snyderman, M.D., effective July 7, 2025. Concurrently, Karen McGinnis and Kevin O’Boyle have accepted appointments to the board of directors. Mark Rubash has served on the board since 2016, prior to th</description>
</item>
<item>
<title>Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference</title>
<link>https://6ix.com/company/outset-medical-inc/news/outset-medical-present-goldman-sachs-130500246</link>
<guid isPermaLink="true">https://6ix.com/company/outset-medical-inc/news/outset-medical-present-goldman-sachs-130500246</guid>
<pubDate>Thu, 05 Jun 2025 13:05:00 GMT</pubDate>
<description>SAN JOSE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the Goldman Sachs 46th annual Healthcare conference on Wednesday, June 11, 2025, at 11:20 a.m. Eastern time. A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://i</description>
</item>
</channel>
</rss>